Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller
Clover Health (NASDAQ:CLOV) has appointed Joseph Oldakowski as Vice President of Finance and Controller, reporting to CFO Peter Kuipers. Oldakowski brings nearly 20 years of healthcare and insurance finance experience, most recently serving as VP and Corporate Controller at Point32Health.
In his new role, Oldakowski will lead Clover's corporate accounting, GAAP, SEC, and statutory financial reporting and tax functions. His prior experience includes leadership positions at EmblemHealth, The Hartford, and MassMutual, along with public accounting experience at Melanson Heath specializing in healthcare audits.
The appointment strengthens Clover's financial leadership as the company focuses on scaling operations and driving profitable growth in its Medicare-focused healthcare business.
Clover Health (NASDAQ:CLOV) ha nominato Joseph Oldakowski Vice Presidente della Finanza e Controller, che riporterà al CFO Peter Kuipers. Oldakowski porta con sé quasi 20 anni di esperienza nella finanza del settore sanitario e assicurativo, avendo ricoperto recentemente il ruolo di VP e Corporate Controller presso Point32Health.
Nel suo nuovo incarico, Oldakowski guiderà le funzioni di contabilità aziendale, reporting finanziario GAAP, SEC e statutario, oltre a quelle fiscali di Clover. La sua esperienza precedente include ruoli di leadership in EmblemHealth, The Hartford e MassMutual, oltre a un'esperienza in contabilità pubblica presso Melanson Heath, specializzata in audit nel settore sanitario.
Questa nomina rafforza la leadership finanziaria di Clover mentre l'azienda si concentra sull'espansione delle operazioni e sulla crescita redditizia nel suo business sanitario focalizzato su Medicare.
Clover Health (NASDAQ:CLOV) ha nombrado a Joseph Oldakowski como Vicepresidente de Finanzas y Controller, reportando al CFO Peter Kuipers. Oldakowski aporta casi 20 años de experiencia en finanzas de salud y seguros, habiendo desempeñado recientemente el cargo de VP y Controller Corporativo en Point32Health.
En su nuevo rol, Oldakowski liderará las funciones de contabilidad corporativa, reportes financieros GAAP, SEC y estatutarios, así como las fiscales de Clover. Su experiencia previa incluye puestos de liderazgo en EmblemHealth, The Hartford y MassMutual, además de experiencia en contabilidad pública en Melanson Heath, especializada en auditorías del sector salud.
Este nombramiento fortalece el liderazgo financiero de Clover mientras la compañía se enfoca en escalar operaciones y promover un crecimiento rentable en su negocio de salud enfocado en Medicare.
Clover Health (NASDAQ:CLOV)� Joseph Oldakowski� 재무 부사장 � 컨트롤러� 임명했으�, CFO Peter Kuipers에게 보고합니�. Oldakowski� 최근 Point32Health에서 부사장 � 기업 컨트롤러� 근무하며 헬스케� � 보험 재무 분야에서 거의 20년의 경험� 보유하고 있습니다.
� 역할에서 Oldakowski� Clover� 기업 회계, GAAP, SEC, 법정 재무 보고 � 세무 기능� 이끌� 됩니�. 이전 경력으로� EmblemHealth, The Hartford, MassMutual에서� 리더� 직책� 헬스케� 감사� 특화� Melanson Heath� 공공 회계 경험� 포함됩니�.
이번 임명은 Clover가 Medicare 중심� 헬스케� 사업에서 운영 규모 확대와 수익� 있 성장� 추진하 가운데 재무 리더십을 강화합니�.
Clover Health (NASDAQ:CLOV) a nommé Joseph Oldakowski au poste de Vice-Président des Finances et Contrôleur, qui rendra compte au CFO Peter Kuipers. Oldakowski apporte près de 20 ans d'expérience en finance dans le secteur de la santé et de l'assurance, ayant récemment occupé le poste de VP et Contrôleur d'entreprise chez Point32Health.
Dans son nouveau rôle, Oldakowski dirigera les fonctions de comptabilité d'entreprise, reporting financier GAAP, SEC et statutaire, ainsi que les fonctions fiscales de Clover. Son expérience antérieure comprend des postes de direction chez EmblemHealth, The Hartford et MassMutual, ainsi qu'une expérience en comptabilité publique chez Melanson Heath, spécialisée dans les audits de santé.
Cette nomination renforce le leadership financier de Clover alors que l'entreprise se concentre sur l'expansion de ses opérations et la croissance rentable de son activité de santé axée sur Medicare.
Clover Health (NASDAQ:CLOV) hat Joseph Oldakowski zum Vice President of Finance und Controller ernannt, der an CFO Peter Kuipers berichtet. Oldakowski bringt fast 20 Jahre Erfahrung im Gesundheits- und Versicherungsfinanzwesen mit und war zuletzt als VP und Corporate Controller bei Point32Health tätig.
In seiner neuen Rolle wird Oldakowski die Bereiche Corporate Accounting, GAAP, SEC sowie die gesetzliche Finanzberichterstattung und Steuerfunktionen bei Clover leiten. Seine vorherigen Positionen umfassen Führungsrollen bei EmblemHealth, The Hartford und MassMutual sowie Erfahrung in der Wirtschaftsprüfung bei Melanson Heath mit Schwerpunkt auf Gesundheitsprüfungen.
Die Ernennung stärkt die Finanzführung von Clover, während das Unternehmen sich darauf konzentriert, die Geschäftstätigkeit zu skalieren und profitables Wachstum im Medicare-fokussierten Gesundheitsgeschäft voranzutreiben.
- None.
- None.
WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health�), a physician enablement company bringing access to great healthcare to everyone on Medicare, today announced the appointment of Joseph (Joe) Oldakowski as Vice President of Finance and Controller. In this role, Mr. Oldakowski reports to Chief Financial Officer Peter Kuipers and will lead Clover’s corporate accounting, GAAP, SEC, and statutory financial reporting and tax function.
Mr. Oldakowski, who joined Clover Health in June, brings nearly two decades of experience in finance and accounting leadership across the healthcare and insurance sectors. He most recently served as Vice President and Corporate Controller at Point32Health, where he led the integration of financial operations following the merger of Harvard Pilgrim Health Care and Tufts Health Plan. In that capacity, he oversaw core finance functions including general accounting, accounts payable, financial reporting, audit coordination, billing, financial systems, accounting policy, and taxation.
Prior to Point32Health, Mr. Oldakowski was Corporate Controller at EmblemHealth, one of the nation’s largest nonprofit health plans, and held progressive leadership roles at The Hartford and MassMutual. He began his career in public accounting with Melanson Heath, now part of Marcum LLP, where he specialized in financial audits for healthcare and nonprofit organizations. He holds a Master’s Degree in Accounting and Taxation from the University of Hartford and a Bachelor’s Degree in Accountancy from Bentley University.
“Joe’s deep technical expertise, track record of leading complex finance transformations, and commitment to integrity make him a strong addition to the Clover leadership team,� said Peter Kuipers, Chief Financial Officer of Clover Health. “As we continue to scale and drive disciplined profitable growth, Joe will play a pivotal role in strengthening our financial infrastructure and supporting our mission to improve every life we touch.�
“I’m excited to join a company that’s redefining healthcare through innovation,� said Oldakowski. “I believe healthcare should be accessible, affordable, and of the highest quality and clinical technology plays a critical role in making that vision a reality.” �
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on and , as well as the earlier identification and management of and .
Visit: www.cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
Press Inquiries:
